Keyphrases
Duchenne muscular Dystrophy
100%
Combined Therapy
100%
Treatment Efficacy
100%
Cell-based
33%
Mini
33%
Pathological Features
33%
Advanced Stage
16%
Muscular Dystrophy
16%
Muscle Weakness
16%
Dystrophin
16%
Maximum Efficiency
16%
Genetic Defects
16%
Muscle Wasting
16%
Therapeutic Strategies
16%
Therapeutic Approaches
16%
Gene Therapy
16%
Gene-based
16%
Dystrophic muscle
16%
Extracellular Matrix Accumulation
16%
Muscle Inflammation
16%
Muscle Degeneration
16%
Fat Accumulation
16%
Low Efficiency
16%
Combined Therapeutic
16%
Targeting Efficiency
16%
Medicine and Dentistry
Muscular Dystrophy
100%
Duchenne Muscular Dystrophy
100%
Combination Therapy
100%
Combined Therapy
100%
Cell Therapy
33%
Muscle Atrophy
33%
Epileptic Absence
16%
Disease
16%
Muscle Weakness
16%
Extracellular Matrix
16%
Dystrophin
16%
Myositis
16%
Genetic Disorder
16%
Lipid Storage
16%
Pharmacology, Toxicology and Pharmaceutical Science
Duchenne Muscular Dystrophy
100%
Muscular Dystrophy
100%
Combination Therapy
100%
Muscle Atrophy
33%
Epileptic Absence
16%
Disease
16%
Muscle Weakness
16%
Dystrophin
16%
Myositis
16%
Genetic Disorder
16%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
Dystrophin
100%
Lipid Storage
100%
Neuroscience
Muscular Dystrophy
100%
Cell Therapy
28%
Epileptic Absence
14%
Muscle Atrophy
14%
Dystrophin
14%
Extracellular Matrix
14%